...
机译:新型非氟化喹诺酮新霉素(TG-873870)对台湾金黄色葡萄球菌,肠球菌和肺炎链球菌的临床分离株具有多种耐药表型的体外活性
1Department of Internal Medicine, Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan 2Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei County, Taiwan 3Division of Clinical Pathology, Department of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan 4TaiGen Biotechnology Co. Ltd, Taipei, Taiwan 5Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan 6Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan;
机译:新型的非氟喹诺酮奈莫沙星(TG-873870)对台湾地区具有多种耐药表型的金黄色葡萄球菌,肠球菌和肺炎链球菌临床分离株的体外活性。
机译:新型非氟化喹诺酮类药物PGE 9262932和PGE 9509924对抗金黄色葡萄球菌和肺炎链球菌临床分离株的体外活性,这些分离株具有DNA促旋酶和拓扑异构酶IV的明确突变。
机译:替加环素对耐喹诺酮类肺炎链球菌,耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌的体外活性
机译:肽聚糖的结构和机械基础,肽因子毒力因子刺痛的因子和来自金黄色葡萄球菌的葡萄球菌和肺炎链球菌肺炎链球菌的毒性因子。
机译:肺炎链球菌外排介导的氟喹诺酮耐药性和体外转化研究。
机译:新型非氟化喹诺酮类药物PGE 9262932和PGE 9509924的体外活性对金黄色葡萄球菌和肺炎链球菌临床分离株的DNA促旋酶和拓扑异构酶IV有明确的突变
机译:新型非氟化喹诺酮类药物PGE 9262932和PGE 9509924的体外活动对金黄色葡萄球菌和肺炎链球菌临床分离株的DNA促旋酶和拓扑异构酶IV有明确的突变